Cetirizine Hydrochloride
NDC 71610-821, Cetirizine Hydrochloride, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-821
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077498
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-821 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-821-30 | 71610082130 | 30 TABLET in 1 BOTTLE (71610-821-30) |
| 71610-821-60 | 71610082160 | 90 TABLET in 1 BOTTLE (71610-821-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71610-821 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-821 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-821. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.